These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 29563616)

  • 1. Type I interferons promote the survival and proinflammatory properties of transitional B cells in systemic lupus erythematosus patients.
    Liu M; Guo Q; Wu C; Sterlin D; Goswami S; Zhang Y; Li T; Bao C; Shen N; Fu Q; Zhang X
    Cell Mol Immunol; 2019 Apr; 16(4):367-379. PubMed ID: 29563616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-α induces altered transitional B cell signaling and function in Systemic Lupus Erythematosus.
    Chang NH; Li TT; Kim JJ; Landolt-Marticorena C; Fortin PR; Gladman DD; Urowitz MB; Wither JE
    J Autoimmun; 2015 Apr; 58():100-10. PubMed ID: 25678471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transitional B cells in quiescent SLE: An early checkpoint imprinted by IFN.
    Dieudonné Y; Gies V; Guffroy A; Keime C; Bird AK; Liesveld J; Barnas JL; Poindron V; Douiri N; Soulas-Sprauel P; Martin T; Meffre E; Anolik JH; Korganow AS
    J Autoimmun; 2019 Aug; 102():150-158. PubMed ID: 31085070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon
    Akita K; Yasaka K; Shirai T; Ishii T; Harigae H; Fujii H
    Front Immunol; 2020; 11():498703. PubMed ID: 33633721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.
    Oke V; Gunnarsson I; Dorschner J; Eketjäll S; Zickert A; Niewold TB; Svenungsson E
    Arthritis Res Ther; 2019 Apr; 21(1):107. PubMed ID: 31036046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE).
    Oke V; Brauner S; Larsson A; Gustafsson J; Zickert A; Gunnarsson I; Svenungsson E
    Arthritis Res Ther; 2017 Jun; 19(1):139. PubMed ID: 28619037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of apoptotic U937 cells and lupus IgG is a potent IFN-alpha inducer.
    Båve U; Alm GV; Rönnblom L
    J Immunol; 2000 Sep; 165(6):3519-26. PubMed ID: 10975873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity.
    Slight-Webb S; Lu R; Ritterhouse LL; Munroe ME; Maecker HT; Fathman CG; Utz PJ; Merrill JT; Guthridge JM; James JA
    Arthritis Rheumatol; 2016 Oct; 68(10):2492-502. PubMed ID: 27059145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B Cell Tetherin: A Flow Cytometric Cell-Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus.
    El-Sherbiny YM; Md Yusof MY; Psarras A; Hensor EMA; Kabba KZ; Dutton K; Mohamed AAA; Elewaut D; McGonagle D; Tooze R; Doody G; Wittmann M; Emery P; Vital EM
    Arthritis Rheumatol; 2020 May; 72(5):769-779. PubMed ID: 31804007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus: A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic Diseases.
    Gupta S; Tatouli IP; Rosen LB; Hasni S; Alevizos I; Manna ZG; Rivera J; Jiang C; Siegel RM; Holland SM; Moutsopoulos HM; Browne SK
    Arthritis Rheumatol; 2016 Jul; 68(7):1677-87. PubMed ID: 26815287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
    Liu M; Liu J; Hao S; Wu P; Zhang X; Xiao Y; Jiang G; Huang X
    Clin Rheumatol; 2018 Oct; 37(10):2675-2684. PubMed ID: 29774490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-α abrogates the suppressive effect of apoptotic cells on dendritic cells in an in vitro model of systemic lupus erythematosus pathogenesis.
    Abeler-Dörner L; Rieger CC; Berger B; Weyd H; Gräf D; Pfrang S; Tarner IH; Schwarting A; Lorenz HM; Müller-Ladner U; Krammer PH; Kuhn A
    J Rheumatol; 2013 Oct; 40(10):1683-96. PubMed ID: 24037549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity.
    Wu Q; Yang Q; Lourenco E; Sun H; Zhang Y
    Arthritis Res Ther; 2011 Jun; 13(3):R88. PubMed ID: 21679442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
    Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
    Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting Edge: Intracellular IFN-β and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells.
    Hamilton JA; Wu Q; Yang P; Luo B; Liu S; Li J; L Mattheyses A; Sanz I; Chatham WW; Hsu HC; Mountz JD
    J Immunol; 2018 Oct; 201(8):2203-2208. PubMed ID: 30201809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High
    Wang T; Marken J; Chen J; Tran VB; Li QZ; Li M; Cerosaletti K; Elkon KB; Zeng X; Giltiay NV
    Front Immunol; 2019; 10():1243. PubMed ID: 31231380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil-mediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus.
    Palanichamy A; Bauer JW; Yalavarthi S; Meednu N; Barnard J; Owen T; Cistrone C; Bird A; Rabinovich A; Nevarez S; Knight JS; Dedrick R; Rosenberg A; Wei C; Rangel-Moreno J; Liesveld J; Sanz I; Baechler E; Kaplan MJ; Anolik JH
    J Immunol; 2014 Feb; 192(3):906-18. PubMed ID: 24379124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-Regulated Interleukin-10 Induced by E2F Transcription Factor 2-MicroRNA-17-5p Circuitry in Extrafollicular Effector B Cells Contributes to Autoantibody Production in Systemic Lupus Erythematosus.
    Xu L; Wang L; Shi Y; Deng Y; Oates JC; Kamen DL; Gilkeson GS; Wang F; Zhang M; Tan W; Tsao BP
    Arthritis Rheumatol; 2022 Mar; 74(3):496-507. PubMed ID: 34569195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.